Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Pfizer announces further product launches for novel quinolone

Dec. 2, 1998

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Improved antibacterial efficacy observed with OPC-20011

Dec. 2, 1998

AMBI seeks partners to develop oral nisin for colon infections

Dec. 1, 1998

New antiparasitic agents in development at Bayer

Dec. 1, 1998

Alkermes, Schering-Plough agree to terminate collaboration

Nov. 30, 1998

Shionogi claims new agents for influenza

Nov. 30, 1998

Antimicrobial and antitumor activity of xenomin compounds described

Nov. 30, 1998

Viral and nonviral serine protease inhibitors developed at Emory University

Nov. 27, 1998

Design, synthesis and antiviral activity of A-5021 discussed this week in Kyoto

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.